Last week, Patrys CEO and MD, Dr James Campbell, presented at the ShareCafe Hidden Gems webinar, where he spoke about the latest developments for the Company’s PAT-DX1 clinical trial, scheduled for the second half of 2023.
Last week, Patrys CEO and MD, Dr James Campbell, presented at the ShareCafe Hidden Gems webinar, where he spoke about the latest developments for the Company’s PAT-DX1 clinical trial, scheduled for the second half of 2023.